Cytoprotective Peptides
KPV
C₁₇H₃₂N₆O₆
Key Research Findings
- Published cell-culture assays on epithelial NF-κB activation.
- In-vitro antimicrobial activity reported in plate-assay studies.
- Stability profile documented in lyophilised form at −20 °C.
Overview
KPV is a synthetic tripeptide fragment of the α-MSH C-terminal sequence. Supplied as a lyophilised powder for in-vitro research use only.
Mechanism of Action
Reported in published in-vitro and animal-model studies to interact with the MC1R melanocortin receptor and the NF-κB signalling pathway in epithelial cell-line assays. Not intended for human or veterinary use.
Research Effects
MC1R Receptor Binding
Extensive ResearchReported in receptor-binding assays as a ligand for the MC1R melanocortin receptor.
NF-κB Pathway Studies
Extensive ResearchCell-culture assays report effects on NF-κB-driven cytokine transcription in epithelial cell lines.
Antimicrobial Plate Assays
Moderate ResearchPublished in-vitro plate assays report activity against S. aureus, E. coli and Candida species.
Research Purposes Only — All information on this page is provided for scientific research purposes only. This product is not intended for human consumption, diagnosis, treatment, or prevention of any disease.
Quick Facts
Research Status Key
Featured in Bundles
KPV is included in the following Zenterex research peptide bundles.
Related Peptides
Cytoprotective Peptides
BPC-157
BPC-157 is a synthetic pentadecapeptide derived from a sequence identified in human gastric juice. Supplied as a lyophilised powder for in-vitro research use only.
Learn More →
Cytoprotective Peptides
TB-500
TB-500 is a synthetic analogue of the thymosin β4 (Tβ4) fragment. Supplied as a lyophilised powder for in-vitro research use only.
Learn More →